Grifols SA ADR (GRFS) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NASDAQ

Key Metrics

• Price: $8.96
• Market Cap: $7.65B
• P/E Ratio: 13.81
• EPS: $0.63
• Dividend Yield: 0.02%
• 52-Week High: $10.96
• 52-Week Low: $6.09

Market Sentiment

Grifols SA ADR currently has a Bullish sentiment score of 0.21.

About Grifols SA ADR

Grifols, SA (Ticker: GRFS) is a prominent global player in the pharmaceutical and biotechnology sectors, recognized for its expertise in the development and distribution of life-saving therapies derived from human plasma. Based in Barcelona, Spain, the company operates a robust network of plasma donation centers and state-of-the-art manufacturing facilities, enabling it to address the needs of patients with rare and chronic diseases effectively. Grifols is committed to innovating healthcare s...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Grifols SA ADR and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

What is GRFS's current dividend yield?

Grifols SA ADR (GRFS) has a current dividend yield of 0.02%.

Does GRFS pay dividends?

Yes, Grifols SA ADR pays dividends with a current yield of 0.02%.

What is GRFS's P/E ratio?

Grifols SA ADR has a price-to-earnings (P/E) ratio of 13.81.

What is GRFS's market cap?

Grifols SA ADR (GRFS) has a market capitalization of $7.65B with a current stock price of $8.96.